Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Concomitant LAAC/AF Ablation (Watchman FLX Pro)

NCT: NCT07041125 · COMPLETED

NCT IDNCT07041125
StatusCOMPLETED
Start Date2025-06-01
Completion2026-06-30
SponsorHeart Rhythm Clinical and Research Solutions, LLC (OTHER)
First posted
Last updated

Brief Summary

This sub-study is a prospective/retrospective, non-randomized, observational, comparative cohorts study, embedded in and expanding on the infrastructure of a real-world AF ablation registry DISRUPT-AF (NCT06335082).

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑